A study with a cohort of 180 patients showed that 78% of T-ALL expressed CD4 and/or CD8 [186], while CD4 and/or CD8 is also highly expressed in PTCL, with varying degrees of expression depending on the subtype [187]. This evidence concerns the gene CD8A and acute lymphoblastic leukemia.